Friday, February 28, 2025

February 28, 2025 at 10:14PM Seasonal Information for Influenza Virus Vaccine

Seasonal Information for Influenza Virus Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WGyhf7P

February 28, 2025 at 10:11PM FDA Plans for Selecting Influenza Virus Strains for Vaccine Composition for the 2025-2026 U.S. Influenza Season

FDA Plans for Selecting Influenza Virus Strains for Vaccine Composition for the 2025-2026 U.S. Influenza Season

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kHXjMCG

February 26, 2025 at 10:04PM MTS Anti-IgG, -C3d Card

Indicated For in vitro blood banking reagent

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/CokQLPg

February 26, 2025 at 04:35PM Artificial Intelligence and Machine Learning (AI/ML) for Biological and Other Products Regulated by CBER

Use of Artificial Intelligence and Machine Learning (AI/ML) has rapidly become an important component of everyday life. This includes using AI/ML in the development of Medical Products, including Biologics. This page provides an overview of CBER's activity in AI/ML.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Nc7UdTg

February 26, 2025 at 01:20PM ACAM2000

ACAM2000 is a product approval indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rte6DvM

Tuesday, February 25, 2025

February 25, 2025 at 03:20PM Sperm Bank, Inc. dba Fertility Center of California - 694273 - 02/14/2025

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/PW0cEXh

Monday, February 24, 2025

February 24, 2025 at 04:13PM FDA 101: How to Use the Consumer Complaint System and MedWatch

If you have a complaint about a product regulated by the Food and Drug Administration (FDA), the agency wants to hear about it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/nLkXR4A

Friday, February 21, 2025

February 21, 2025 at 09:13PM ABRYSVO

ABRYSVO is an active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older...

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/foSqGRc

February 21, 2025 at 04:49PM Biological Approvals by Year

A collection of biological approval information organized by year and regulatory authorities.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qiOaRZF

February 21, 2025 at 03:35PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Public Engagement Staff draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/l5S6eMZ

Thursday, February 20, 2025

February 20, 2025 at 08:50PM OTP Events, Meetings, and Workshops

Office of Therapeutic Products Events, Meetings, and Workshops

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/yMYJwN9

February 20, 2025 at 04:53PM Have You Given Blood Lately?

The FDA works to ensure the safety of millions of units of blood and blood components donated in the U.S. each year. Learn how the FDA helps safeguard the blood supply and how you can donate blood.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dy06wn8

Wednesday, February 19, 2025

February 19, 2025 at 07:30PM Recommendations to Reduce the Risk of Transmission of Hepatitis B Virus (HBV) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

This is the Draft Guidance for Industry - Recommendations to Reduce the Risk of Transmission of Hepatitis B Virus (HBV) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rEyzcjd

February 19, 2025 at 03:07PM eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4iVUBFe

Tuesday, February 18, 2025

February 18, 2025 at 10:42PM Safety & Availability (Biologics)

Important information about the safety and availability of biological products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xsoBOY7

February 18, 2025 at 09:19PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/q8ATK0O

February 18, 2025 at 06:39PM Artificial Intelligence for Drug Development

FDA recognizes the increased use of AI throughout the drug development process and across a range of therapeutic areas. Learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ojXBx2d

February 18, 2025 at 05:40PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Jp3Ka0l

Friday, February 14, 2025

February 12, 2025 at 04:13PM Increasing Options in Clinical Research to Facilitate Medical Product Development

FDA issued a final rule to help advance medical product development without compromising the rights, safety and welfare of people participating in clinical research.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rKq4w3t

February 12, 2025 at 03:37PM Realizing the Promise of Real-World Evidence

Realizing the full potential of RWE in regulatory decision-making presents several challenges, and work is underway at the FDA to better understand this area.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/oea1ygV

February 15, 2025 at 12:28AM Vaccines Licensed for Use in the United States

The product name and trade name of vaccines licensed for use in the United States.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mY3IjsU

February 14, 2025 at 09:36PM Cellular, Tissue, and Gene Therapies Advisory Committee November 21, 2024 Meeting Announcement - 11/21/2024

This is the main page for the CBER Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) November 21, 2024 announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/1BDbIpi

February 14, 2025 at 05:34PM 10 Facts about What FDA Does and Does Not Approve

Is It Really "FDA Approved"? Maybe you’ve seen these words on a company’s website or in a commercial promoting a product or treatment. Here are some facts about products that are, and aren’t, FDA approved.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MLogl3a

February 14, 2025 at 02:14PM Individual Case Safety Reports

This web page is dedicated to the health and regulatory data standard: Individual Case Safety Report

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jVsdn45

Thursday, February 13, 2025

February 13, 2025 at 06:50PM Ticks and Lyme Disease: Symptoms, Treatment, and Prevention

Lyme disease is on the rise. How can you prevent it? What are the symptoms, and what should you do if you think you or your pet have it?

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/JlItFKR

February 13, 2025 at 05:50PM Should Your Child Participate in a Clinical Trial?

Clinical trials give us important information about the safety and effectiveness of a treatment. Before deciding whether your child should join a clinical trial, learn as much as you can, including the risks and benefits.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/v4T1qsQ

February 13, 2025 at 05:23PM POSTPONED: Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZgEvRKP

Wednesday, February 12, 2025

February 12, 2025 at 10:49PM Know Your Treatment Options for COVID-19

Patients today have several treatment options to prevent hospitalization and other serious complications of COVID-19. The FDA has approved drug treatments for COVID-19 and has authorized others for emergency use.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/EzG3XM6

February 12, 2025 at 04:13PM Increasing Options in Clinical Research to Facilitate Medical Product Development

FDA issued a final rule to help advance medical product development without compromising the rights, safety and welfare of people participating in clinical research.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/AC1zD9K

February 12, 2025 at 03:37PM Realizing the Promise of Real-World Evidence

Realizing the full potential of RWE in regulatory decision-making presents several challenges, and work is underway at the FDA to better understand this area.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/IeEYSwh

Tuesday, February 11, 2025

February 12, 2025 at 04:01AM Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies

Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lRsoOer

February 11, 2025 at 09:08PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/nADcXv1

February 11, 2025 at 09:01PM CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

CDER Scientific Reviews Supporting EUA for Therapeutic Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/JTFW53l

February 11, 2025 at 07:30PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/CtieWyO

Monday, February 10, 2025

February 10, 2025 at 03:12PM The Concerning Trend in Men’s Health

Despite spending more on healthcare than any other nation on earth, life expectancy in the U.S. is trending downward.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/OITQNzo

Saturday, February 8, 2025

February 03, 2025 at 07:25AM Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Vaccine or Related Product

Guidance for Industry: Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Vaccine or Related Product, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/N7rq2SM

February 03, 2025 at 07:10AM Providing Regulatory Submissions to the Center for Biologics Evaluation and Research (CBER) in Electronic Format - Biologics Marketing Applications

This is the Providing Regulatory Submissions to the Center for Biologics Evaluation and Research (CBER) in Electronic Format - Biologics Marketing Applications, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0CksVL1

February 03, 2025 at 06:50AM Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods - Technical Correction February 2001

This is the Guidance for Industry: Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods - Technical Correction February 2001.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/glKLHky

Friday, February 7, 2025

February 07, 2025 at 10:16PM Description of FDA Forms for Export Certification

Description of FDA Forms for Export Certification

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/JZszeaf

February 07, 2025 at 05:48PM International Activities

CBER’s international activities can be categorized in the following functional areas: regulatory harmonization, regulatory capacity building, information sharing, international standards setting, and collaborative research.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/pAYHiRE

Thursday, February 6, 2025

February 06, 2025 at 10:22PM Biologics Electronic Reading Room (eFOIA)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7rGvNPy

February 06, 2025 at 04:12PM Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Ymc583E

January 31, 2025 at 07:32PM Premarketing Risk Assessment

Guidance for Industry - Premarketing Risk Assessment, Clinical/Medical

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zFp03gM

Wednesday, February 5, 2025

February 05, 2025 at 03:13PM Institutional Review Boards Frequently Asked Questions

IRB Information Sheet - Frequently Asked Questions

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bk97zZF

February 05, 2025 at 02:49PM Evaluation of Sex Differences in Clinical Investigations

Evaluation of Sex Differences in Clinical Investigations - IRB Information Sheet

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/H5B34YT

Tuesday, February 4, 2025

February 04, 2025 at 09:48PM Blood & Blood Products

CBER regulates the collection of blood and blood components used for transfusion or for the manufacture of pharmaceuticals derived from blood and blood components. FDA has strengthened the safeguards that protect patients from unsuitable blood and blood products and has increased its oversight of t

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zoCL1wS

February 04, 2025 at 04:35PM Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

Draft Guidance for Industry: Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8s0x65S

February 04, 2025 at 03:20PM BioStem Life Sciences - 673788 - 01/17/2025

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5z2dYJX

Sunday, February 2, 2025

February 03, 2025 at 05:54AM Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials

Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials, CBER, Biiologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dWCq45H

February 03, 2025 at 05:41AM Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications

Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9sIhian

February 03, 2025 at 05:25AM Preclinical Assessment of Investigational Cellular and Gene Therapy Products

Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products, CBER, Biologics


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XVDfy6e

February 03, 2025 at 05:05AM Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271

Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271 Guidance for Industry, cber, biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vrzYMBR